They will either meet at the time of resubmission or to discuss the results of the resubmission once the FDA has had time to review.
If approval is given, there will be a meeting for backslapping and happy snaps. If the re-submission is knocked back in any way then there will be a meeting to cover off the 'legalities' and/or future hoop designs.
It's a given there will be more meetings. More than one!
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD, page-87
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |